PEBC (Psychiatric and Neurological Drugs) Sample Questions Set-10
Categories: PEBC Canada
Ques. RJ a 34 year old patient who has been getting his prescriptions filled at your pharmacy for a long time. He has been taking paroxetine 40 mg per day for two years for the treatment of obsessive-compulsive disorder, with good results. He used to have obsessions of doubt, leading to compulsive checking, which virtually incapacitated him. He wasn’t able to leave the house for fear that the stove had been left on, or that the door wasn’t locked. He has talked to his psychiatrist about stopping the medication and he asks for your opinion. Which of the following is correct?
a. he will not relapse after discontinuation since he took the medication for two years
b. he must stay on medication for at least five years to reduce the risk of relapse
c. he has been on medication too long already
d. he may or may not relapse if the medication is stopped.
Answer: (d)
Ques. RJ after a discussion with his physician, decides to stop the paroxetine. Which of the following would represent the best advice for him?
a. taper down the dose of paroxetine slowly
b. stop the paroxetine at once and take prn doses of diazepam if required
c. stop the paroxetine at once and monitor symptoms
d. substitute paroxetine with fluoxetine for two weeks then stop
Answer: (a)
Ques. One year after stopping the paroxetine, RJ notices the return of some of his symptoms. He is reluctant to take medication again because he does not want to have to take medications for the rest of his life. Which of the following statements is correct with respect to treatment of OCD?
a) cognitive-behavioral therapy has not been shown to be effective
b) cognitive-behavioral therapy is as effective as pharmacotherapy
c) pharmacotherapy is much more effective than cognitivebehavioural therapy
d) cognitive-behavioral therapy should be tried before pharmacotherapy is offered
Answer: (d)
Ques. JDs doctor would like to start her on combination pharmacotherapy with an anxiolytic and an antidepressant. Which of the following SSRIs would be most likely to have a pharmacokinetic interaction with a benzodiazepine?
a) citalopram
b) Fluvoxamine
c) paroxetine
d) sertraline
Answer: (b)
Ques. You implement a plan to monitor the therapeutic outcomes of Ms L’s pharmacotherapy. Which of the following best describes the goals of treatment for panic disorder?
a. reduce the number of panic attacks and the degree of anticipatory anxiety
b. reduce the number of symptoms experienced during a panic attack
c. reduce the time it takes for symptoms to peak during a panic attack
d. reduce the number of panic attacks
Answer: (a)
Ques. A 44 year old patient with epilepsy, he is using valproic acid 500mg TID. For the past 6 months He has had a good response, however he is experiencing some side effects like stomach upset. The pharmacist should advise the patient:
I) Talk to doctor to reduce the dose
II) Talk to doctor to switch him to liquid form
III) Talk to doctor to give him another medication in the same class (divalproex)
A) I only
B) III only
C) I and II
D) II and III
E) I, II, III
Answer: (b)
Ques. Folic acid deficiency will affect which of the following antiepileptic drugs?
I) carbamazepine
II) valproic acid
III) phenytoin
A) I only
B) III only
C) I and II
D) II and III
E) I, II, III
Answer: (b)
Ques. A patient came to emergence poisoned with diphenhydramine, amitriptyline, and imipramine. What are the symptoms?
a. dry mouth
b. tinnitus
c. constipation
d. sedation
e. all of the above
Answer: (e)